{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:09:02Z","timestamp":1771416542272,"version":"3.50.1"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,18]]},"abstract":"<jats:p>Psoriasis and other chronic inflammatory skin diseases present unique therapeutic challenges in people living with HIV (PLHIV). Historically, concerns regarding immunosuppression and the risk of opportunistic infection have limited the use of systemic and biologic therapies in this population. Although the advent of effective antiretroviral therapy has markedly improved immune function and life expectancy, robust evidence guiding the management of moderate-to-severe psoriasis in PLHIV remains scarce.<\/jats:p>","DOI":"10.1093\/bjd\/ljaf493","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T12:56:45Z","timestamp":1764421005000},"page":"568-570","source":"Crossref","is-referenced-by-count":0,"title":["Biologic and small-molecule therapies for chronic plaque psoriasis in people living with HIV: current evidence and clinical practical considerations"],"prefix":"10.1093","volume":"194","author":[{"given":"Nicholas","family":"van Rooij","sequence":"first","affiliation":[{"name":"Queensland Health , Brisbane, Queensland ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arron","family":"Sparkes","sequence":"additional","affiliation":[{"name":"Queensland Health , Brisbane, Queensland ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"2026021806323088800_ljaf493-B1","first-page":"284","article-title":"Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies","volume":"17","author":"Nakamura","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"2026021806323088800_ljaf493-B2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00403-024-03395-1","article-title":"Systematic review of biologic use for psoriasis in HIV-positive individuals from 2018 to 2024","volume":"317","author":"Shimon","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"2026021806323088800_ljaf493-B3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.33590\/emjdermatol\/10301865","article-title":"The safety profile of biological agents in patients with psoriasis and HIV: a systematic review","volume":"11","author":"Mostafa","year":"2023","journal-title":"EMJ Dermatol"},{"key":"2026021806323088800_ljaf493-B4","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19020","article-title":"The impact of psoriasis biologic therapy on HIV viral load and CD4+ cell counts in HIV-positive individuals: a real-world cohort study","author":"Xu","year":"2023  10","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026021806323088800_ljaf493-B5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12981-024-00675-8","article-title":"Ixekizumab: an alternative for HIV-positive psoriasis patients","volume":"21","author":"Liu","year":"2024","journal-title":"AIDS Res Ther"},{"key":"2026021806323088800_ljaf493-B6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/2475530320954279","article-title":"Biologic treatment of 4 HIV-positive patients: a case series and literature review","volume":"6","author":"Myers","year":"2021","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"2026021806323088800_ljaf493-B7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaad.2024.02.042","article-title":"Use of biologic treatment in psoriasis patients with HIV: a systematic review","volume":"91","author":"Sood","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2026021806323088800_ljaf493-B8","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/jdv.19177","article-title":"Managing psoriasis in HIV-positive patients in the era of biologics","volume":"37","author":"Belinch\u00f3n Romero","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf493\/65663248\/ljaf493.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/3\/568\/65663248\/ljaf493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/3\/568\/65663248\/ljaf493.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T11:32:37Z","timestamp":1771414357000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/3\/568\/8361902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":8,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12,1]]},"published-print":{"date-parts":[[2026,2,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf493","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,12,1]]}}}